Peter's research and interests are focused on applying engineering mindsets to solve complex immunological problems by utilizing interesting chemical approaches. He has always been interested in both engineering solutions and immunology ever since he was a kid growing up in Columbus, Ohio. Due to his severe peanut allergy, he has always been interested in immunology, but his penchant for engineering was fostered during his undergraduate experience at the University of Dayton, where he majored in chemical engineering. After this, he attended the University of Notre Dame, where he worked on developing novel diagnostics and targeted therapies for food and drug allergies. He joined the Esser-Kahn group to continue fostering and growing his love of immunology, chemistry and engineering by working on designing new systems for both vaccines and autoimmune diseases which utilize innate immunity.
Bioengineering, University of Notre Dame (2016)
Advisor: Dr. Basar Bilgicer
Dissertation: “Inhibitors for Allergic Reactions to Peanuts and Drugs: Epitope
Analysis, Molecular Design and Characterization”
Chemical Engineering, University of Dayton (2012)
“The things that we love tell us what we are.”- St. Thomas Aquinas
Characterizing unique Toll-like receptor-sensitive dendritic cell sub-states
Inducing tolerogenic antigen presenting cell phenotypes
Determining Whether Agonist Density or Agonist Number Is More Important for Immune Activation via Micoparticle Based Assay
Deak P, Kimani F, Cassaidy B, Esser-Kahn A. Determining Whether Agonist Density or Agonist Number Is More Important for Immune Activation via Micoparticle Based Assay. Front Immunol. 2020;11:642. doi: 10.3389/fimmu.2020.00642. eCollection 2020. PubMed PMID: 32328073; PubMed Central PMCID: PMC7161694.